Cardioplegia Solution Recalled Due to Sterility Assurance Failure
Central Admixture Pharmacy Services is recalling 356 bags of cardioplegia solution distributed nationwide. The recall is due to lack of assurance of sterility, as validation data for decontamination cycles is lacking.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a high-risk injectable product used directly in critical cardiac surgery where sterility is essential. The recall is based on lack of sterility assurance (validation data for decontamination cycles is lacking). However, no illnesses or injuries have been reported and no contamination has been confirmed, classifying this as a theoretical risk-of-harm situation and qualifying for Score 3 per the rubric.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling Cardioplegia Solution, low K, Maintenance 4:1 Plasmalyte (NDC: 72196-0211-1) distributed nationwide. The recall involves 356 bags.
The product is being recalled due to lack of assurance of sterility. Specifically, validation data for decontamination cycles is lacking. This validation is necessary to ensure the product is free from microbial contamination.
Cardioplegia solution is an IV medication administered directly during cardiac surgery. The affected lot numbers and expiration dates are: 36-251457 (Exp. 7/14/2023), 36-253952 (Exp. 7/20/2023), 36-255944 (Exp. 7/27/2023), and 36-257101 (Exp. 7/31/2023). Healthcare providers should reference the FDA recall notice for guidance on this product.
The recalled product
- Product
- Cardioplegia Solution, low K, Maintenance 4:1 Plasmalyte, Low Potassium, IV Bag, total volume = 1047 mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0211-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Affected units
- 356
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (8)
- Lot: 36-251457
- Exp. 7/14/2023
- 36-253952
- Exp. 7/20/2023
- 36-255944
- Exp. 7/27/2023
- 36-257101
- Exp. 7/31/2023.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 95 recalled by Central Admixture Pharmacy Services, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 95 products in this recall →Related recalls
Same manufacturer · Central Admixture Pharmacy Services, Inc.
See all →- ModeratePediatric TPN Bags Recalled for Incorrect Formulation
FDA (Drugs) · 2026-08-12
- SeverePediatric Total Parenteral Nutrition Bag Recalled for Incorrect Formulation
FDA (Drugs) · 2026-07-01
- SevereInjectable Phenylephrine Solution Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2025-03-19
- HighInjectable Lidocaine Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2023-10-11
- HighMidazolam Injectable Solution Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2023-10-11
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22